Coignard, J.,
Lush, M.,
Beesley, J.,
O’Mara, T.A.,
Dennis, J,
Tyrer, J.P.,
Barnes, D.R.,
McGuffog, L.,
Leslie, G.,
Bolla, M.K.,
Adank, M.A.,
Kiiski, J.I.,
Nevanlinna, H.,
team of authors (2021) may exist but studies of mutation carriers have so far been underpowered. We
conduct a novel case
AKHMADIEV, N.S.,
AKHMETOVA, V.R.,
IBRAGIMOV, A.G.,
GALIMOVA, A.M.,
GALIMOVA, R.A.,
AGLETDINOV, E.F.,
KATAEV, V.A.,
KHAIRULLINA, V.R. (2019) ), a number of preclinical trials has been
conducted Methods: 2D and 3D structures
Zelinska, N.,
Iotova, V.,
Skorodok, J.,
Malievsky, O.,
Peterkova, V.,
Samsonova, L.,
Rosenfeld, Ron G.,
Zadik, Zvi,
Jaron-Mendelson, Michal,
Koren, Ronit,
Amitzi, Leanne,
Raduk, Dmitri,
Hershkovitz, Oren,
Hart, Gili (2017) doses, compared with daily recombinant human GH (r-hGH).
Setting: The trial was
conducted in 14
YANG, G.,
SUN, J.,
ZHANG, D.,
ZHANG, R.,
ZHONG, Y.,
WANG, X.,
CHEN, X.,
LIU, B.,
LI, L.,
ZHAO, S.,
WANG, L.,
YUAN, C.,
LONG, M.,
JIANG, H.,
LI, C.,
ZHOU, Q.,
LIAN, A.,
GAREEV, I. (2020) conducted a retrospective study on 364 acute ICH patients from January to December 2016. The primary outcome
educational organization was
conducted, and model of managing the process of development of the information
Zhou, Qi,
Zhang, Daming,
Chen, Xin,
Yang, Zhao,
Liu, Zhihui,
Wei, Baixing,
Jin, Mei,
Feng, Kairu,
Guo, Chunmei,
Sun, Junying,
Chen, Sheng,
Zhang, Ruijia,
Piao, Xiai,
Gareev, Ilgiz,
Sun, Zhenying,
Wang, Xiaoxiong,
Li, Lili,
Zhao, Shiguang,
Yang, Guang (2020) medical center was
conducted. Functional outcome at three months after ICH was dichotomized using
Timasheva, Y,
Badykov, M,
Akhmadishina, L,
Nasibullin, T,
Badykova, E,
Pushkareva, A,
Plechev, V,
Sagitov, I,
Zagidullin, N (2021) Sick sinus syndrome (SSS) encompasses a group of
conduction disorders characterized
Nazarova, Liliia Sh.,
Danilko, Ksenia V.,
Malievsky, Viktor A.,
Karimov, Denis O.,
Bakirov, Akhat B.,
Viktorova, Tatyana V. (2022) from the Republic of Bashkortostan. Genotyping was
conducted via the real-time polymerase chain
CONNORS, J.M.,
SAVAGE, K.J,
JURCZAK, W,
LECH-MARANDA, E.,
SMOLEWSKI, P,
WALEWSKI, J,
STRAUS, D.J.,
YOUNES, A.,
ANSELL, S.M.,
KIM, W.S.,
GALLAMINI, A.,
ALEKSEEV, S.,
ILLÉS, A.,
ROSTA, A.,
PICARDI, M.,
ZINZANI, P.L.,
OKI, Y.,
FELDMAN, T.,
BARTLETT, N.L.,
CHEN, R.,
RAMCHANDREN, R.,
CUNNINGHAM, D.,
RADFORD, J.,
JOSEPHSON, N.C.,
SONG, E.,
SACHS, J.,
JOLIN, H.A.,
HUEBNER, D.,
LIU, R.,
LIPATOV, O.N. (2018)
for relapsed and refractory Hodgkin’s lymphoma.
METHODS
We
conducted an open-label, multicenter, randomized
